Larvol Delta - Aptinyx-Reports-Results-from-Phase-2-Study-of-NYX458-in-Cognitive-Impairment-Associated-with-Parkinson39s-Disease-and-Dementia-with-Lewy-Bodies-and-Provides-Pipeline-and-Corporate-Update

NYX-458 - Aptinyx

https://www.businesswire.com/news/home/20230227005764/en/Aptinyx-Reports-Results-from-Phase-2-Study-of-NYX-458-in-Cognitive-Impairment-Associated-with-Parkinsons-Disease-and-Dementia-with-Lewy-Bodies-and-Provides-Pipeline-and-Corporate-Update

Feb 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next